Aviva Portfolio holdings
AUM
$48.4B
1-Year Return
24.25%
This Quarter Return
+22.94%
1 Year Return
+24.25%
3 Year Return
+97.85%
5 Year Return
+166.96%
10 Year Return
+393.57%
AUM
$16B
AUM Growth
+$2.39B
(+18%)
Cap. Flow
-$410M
Cap. Flow
% of AUM
-2.55%
Top 10 Holdings %
Top 10 Hldgs %
24.43%
Holding
979
New
49
Increased
147
Reduced
723
Closed
36
Top Buys
| 1 |
Union Pacific
UNP
|
+$107M |
| 2 |
Alcon
ALC
|
+$88.1M |
| 3 |
Otis Worldwide
OTIS
|
+$75.5M |
| 4 |
Marsh & McLennan
MMC
|
+$53M |
| 5 |
Merck
MRK
|
+$48.8M |
Top Sells
| 1 |
RTN
Raytheon Company
RTN
|
+$56M |
| 2 |
Amazon
AMZN
|
+$44.3M |
| 3 |
JPMorgan Chase
JPM
|
+$42.3M |
| 4 |
AGN
Allergan plc
AGN
|
+$36.5M |
| 5 |
Microsoft
MSFT
|
+$32.6M |
Sector Composition
| 1 | Technology | 22.31% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 13.68% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Dolby
DLB
$6.93B
| $2.28M | 0.01% |
34,542
-33,088
| -49% | -$2.18M |
|
|
AVLR
727
DELISTED
Avalara, Inc.
AVLR
| $2.28M | 0.01% |
+17,095
| New | +$2.28M |
|
|
MRTX
728
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.27M | 0.01% |
19,911
-26,816
| -57% | -$3.06M |
|
|
Y
729
DELISTED
Alleghany Corporation
Y
| $2.27M | 0.01% |
4,647
+1,389
| +43% | +$679K |
|
|
LOGM
730
DELISTED
LogMein, Inc.
LOGM
| $2.27M | 0.01% |
26,777
-16,819
| -39% | -$1.43M |
|
731
Viking Therapeutics
VKTX
$2.84B
| $2.27M | 0.01% |
314,580
-280,121
| -47% | -$2.02M |
|
732
Ionis Pharmaceuticals
IONS
$10.3B
| $2.27M | 0.01% |
38,449
-37,284
| -49% | -$2.2M |
|
733
Coterra Energy
CTRA
$18.2B
| $2.27M | 0.01% |
131,845
-8,910
| -6% | -$153K |
|
|
XLRN
734
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.26M | 0.01% |
23,753
-18,680
| -44% | -$1.78M |
|
735
Watts Water Technologies
WTS
$9.21B
| $2.26M | 0.01% |
27,928
-17,126
| -38% | -$1.39M |
|
|
VER
736
DELISTED
VEREIT, Inc.
VER
| $2.26M | 0.01% |
70,363
+20,549
| +41% | +$661K |
|
737
Maximus
MMS
$4.93B
| $2.26M | 0.01% |
32,100
-32,406
| -50% | -$2.28M |
|
|
ACIA
738
DELISTED
Acacia Communications, Inc. Common Stock
ACIA
| $2.26M | 0.01% |
33,611
-20,302
| -38% | -$1.36M |
|
|
ALLK
739
DELISTED
Allakos
ALLK
| $2.26M | 0.01% |
+31,381
| New | +$2.26M |
|
740
Protolabs
PRLB
$1.18B
| $2.24M | 0.01% |
19,950
-28,616
| -59% | -$3.22M |
|
741
Boston Beer
SAM
$2.43B
| $2.24M | 0.01% |
4,171
-6,188
| -60% | -$3.32M |
|
742
Interpublic Group of Companies
IPG
$9.74B
| $2.22M | 0.01% |
129,508
-6,186
| -5% | -$106K |
|
743
DaVita
DVA
$9.77B
| $2.22M | 0.01% |
28,061
-3,807
| -12% | -$301K |
|
744
Neurocrine Biosciences
NBIX
$14.3B
| $2.22M | 0.01% |
18,199
-22,144
| -55% | -$2.7M |
|
745
SEI Investments
SEIC
$10.7B
| $2.2M | 0.01% |
40,000
-4,603
| -10% | -$253K |
|
746
Lear
LEA
$5.91B
| $2.19M | 0.01% |
20,072
-1,370
| -6% | -$149K |
|
747
Immunovant
IMVT
$2.86B
| $2.19M | 0.01% |
+89,738
| New | +$2.19M |
|
748
Y-mAbs Therapeutics
YMAB
$390M
| $2.17M | 0.01% |
50,206
-82,407
| -62% | -$3.56M |
|
|
GBT
749
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.17M | 0.01% |
34,345
-36,686
| -52% | -$2.32M |
|
750
GDS Holdings
GDS
$6.56B
| $2.16M | 0.01% |
27,100
+5,230
| +24% | +$417K |
|